Filter Search


Healthcare and Medical


Location Summary Deadline
Germany The Gwq Serviceplus Ag Intends To Conclude Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V For The Active Ingredient Abiraterone With A Strength Of 500mg And A Package Size Of 90 Tablets, Starting From 01/10/2025. This Contract Will Be 2026-03-04
Congo Democratic Republic of Supply Contract For The Acquisition, Installation And Maintenance Of Medical Equipment In The Democratic Republic Of Congo 2026-03-04
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Trientine, Atc A16ax12 For The Period May 1st, 2024 April 30th, 2026 2026-03-05
Germany Open House Drug Discount Agreements Levothyroxine Sodium, Atc H03aa01 2026-03-05
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Molsidomin, Atc C01dx12 For The Period May 1st, 2024 April 30th, 2026 2026-03-05
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Megestrol, Atc L02ab01 For The Period May 1st, 2024 April 30th, 2026 2026-03-05
Germany Open House Drug Discount Agreements Eptinezumab, Atc N02cd05 2026-03-05
Germany Open House Drug Discount Agreements Clindamycin And Benzoyl Peroxide, Atc D10af54 2026-03-05
Germany Open House Drug Discount Agreements Clobetasol, Atc D07ad01 2026-03-05
Norway Rfi - Id/ast For Clinical Medical Microbiology 2026-03-05
Whats app